R&D Systems Inc. Tocris Bioscience Boston Biochem

AT 1015

Cat. No. 4468

AT 1015 C29H33N3O2.HCl [190508-50-0]

Price and Availability

For AT 1015 pricing & availability please select your country from the drop down menu:
Submit
By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Chemical Name: N-[2-[4-(5H-Dibenzo[a,d]cyclohepten­-5-ylidene)-1-piperidinyl]ethyl]-1-formyl-4-piperi­dinecarboxamide hydrochloride

Biological Activity

Long-acting 5-HT2A receptor antagonist; inhibits vasoconstriction and blocks platelet aggregation. Prolongs clotting time in a rat model of thrombus formation; ameliorates laurate-induced peripheral vascular lesions in rodents.

Technical Data

M.Wt:
492.05
Formula:
C29H33N3O2.HCl
Solubility:
Soluble to 100 mM in water and to 100 mM in DMSO
Purity:
>97 %
Storage:
Store at +4°C
CAS No:
190508-50-0

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch
Safety Data Sheet: View Safety Data Sheet

References

Kihara et al (2000) AT-1015, a novel serotonin (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2A receptors and prevents the laurate-induced peripheral vascular lesions in rats. J.Cardiovasc.Pharmacol. 35 523. PMID: 10774780.

Kihara et al (2001) Antithrombotic activity of AT-1015, a potent 5-HT(2A) receptor antagonist, in rat arterial thrombosis model and its effect on bleeding time. Eur.J.Pharmacol. 433 157. PMID: 11755147.

Rashid et al (2001) Assessment of affinity and dissociation ability of a newly synthesized 5-HT2 antagonist, AT-1015: comparison with other 5-HT2 antagonists. Jpn.J.Pharmacol. 87 189. PMID: 11885967.

If you know of a relevant citation for this product please let us know.

View Related Products by Target

Keywords: AT 1015, supplier, AT1015, supplier, serotonin, 5-HT2, receptor, antagonists, vasoconstriction, antithrombotics, antiplatelet, aggregation

Quick Order

Find multiple products by catalog number

divider line

5-HT Review

5-HT Review

Written by Nicholas Barnes and John Neumaier, leading experts. Request a copy or view PDF today.

divider line

7-TM Receptor Signaling

Written by T. Kenakin et al

7-TM Poster

'Seven Transmembrane Receptor Signaling' highlights the multiple behaviors of 7-TMs including G-protein-dependent and -independent signaling as well as the concept of collateral efficacy

divider line

Neurobiology of Parkinson's Disease

Written by A. Schapira

Parkinson's Poster

'Neurobiology and Therapeutics of Parkinson's Disease' highlights the neurobiology of Parkinson's disease and summarizes current and novel therapeutic interventions.

divider line

Regulation of Vascular Reactivity by GPCRs

Written by J.J. Maguire and A.P. Davenport

Cardiovascular Poster

'Regulation of Vascular Reactivity by G-protein-coupled Receptors' summarizes the key GPCRs regulating vascular reactivity.

divider line

Antidepressants - Current and Future Targets

Written by P. Skolnich et al

Antidepressants poster

'Antidepressants - Current and Future Targets' provides an overview of the current and future targets for the treatment of major depressive disorder.

divider line

New Product Guide

NPG

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

divider line

New Products in this Area

EMD 281014 hydrochloride

Selective 5-HT2A antagonist

Quetiapine hemifumarate

5-HT2/D2 antagonist; atypical antipsychotic

S 32212 hydrochloride

5-HT2C inverse agonist; α2 antagonist

Sign-up for new product e-alerts
divider line

Tocris Events

Win a Kindle

ENDO 2013

ENDO 2013

June 15 - 18, 2013

San Francisco, CA

Booth Number: 1032